351 related articles for article (PubMed ID: 32850862)
1. Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming.
Lai X; Li Q; Wu F; Lin J; Chen J; Zheng H; Guo L
Front Cell Dev Biol; 2020; 8():760. PubMed ID: 32850862
[TBL] [Abstract][Full Text] [Related]
2. Current understanding and future perspectives of the roles of sirtuins in the reprogramming and differentiation of pluripotent stem cells.
Hsu YC; Wu YT; Tsai CL; Wei YH
Exp Biol Med (Maywood); 2018 Mar; 243(6):563-575. PubMed ID: 29557214
[TBL] [Abstract][Full Text] [Related]
3. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
[TBL] [Abstract][Full Text] [Related]
4. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation.
Li L; Li W
Pharmacol Ther; 2015 Jun; 150():33-46. PubMed ID: 25595324
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.
Morandi A; Taddei ML; Chiarugi P; Giannoni E
Front Oncol; 2017; 7():40. PubMed ID: 28352611
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.
Chen T; You Y; Jiang H; Wang ZZ
J Cell Physiol; 2017 Dec; 232(12):3261-3272. PubMed ID: 28079253
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy.
Sun NY; Yang MH
Front Oncol; 2020; 10():792. PubMed ID: 32509584
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of studying epithelial-mesenchymal plasticity in pluripotent stem cells.
Kovacic B; Rosner M; Schipany K; Ionce L; Hengstschläger M
Eur J Clin Invest; 2015 Apr; 45(4):415-22. PubMed ID: 25646864
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
13. Transitions between epithelial and mesenchymal states during cell fate conversions.
Li X; Pei D; Zheng H
Protein Cell; 2014; 5(8):580-91. PubMed ID: 24805308
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States.
Sung JY; Cheong JH
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917859
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer.
Bhattacharya D; Scimè A
Front Endocrinol (Lausanne); 2019; 10():773. PubMed ID: 31849832
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells.
Høffding MK; Hyttel P
Stem Cell Res; 2015 Jan; 14(1):39-53. PubMed ID: 25506910
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β.
Valcourt U; Carthy J; Okita Y; Alcaraz L; Kato M; Thuault S; Bartholin L; Moustakas A
Methods Mol Biol; 2016; 1344():147-81. PubMed ID: 26520123
[TBL] [Abstract][Full Text] [Related]
18. Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition.
Chen XL; Lei L; Hong LL; Ling ZQ
Histol Histopathol; 2018 Jul; 33(7):655-663. PubMed ID: 29285747
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming.
Nishimura K; Fukuda A; Hisatake K
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067778
[TBL] [Abstract][Full Text] [Related]
20. Catabolic metabolism during cancer EMT.
Cha YH; Yook JI; Kim HS; Kim NH
Arch Pharm Res; 2015 Mar; 38(3):313-20. PubMed ID: 25634102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
